Agilysys Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Agilysys has a total shareholder equity of $260.3M and total debt of $50.0M, which brings its debt-to-equity ratio to 19.2%. Its total assets and total liabilities are $442.0M and $181.7M respectively. Agilysys's EBIT is $23.1M making its interest coverage ratio -4.5. It has cash and short-term investments of $54.9M.

Anahtar bilgiler

19.2%

Borç/özkaynak oranı

US$50.00m

Borç

Faiz karşılama oranı-4.5x
NakitUS$54.89m
EşitlikUS$260.26m
Toplam yükümlülüklerUS$181.75m
Toplam varlıklarUS$442.01m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Returns Are Gaining Momentum At Agilysys (NASDAQ:AGYS)

Oct 18
Returns Are Gaining Momentum At Agilysys (NASDAQ:AGYS)

When Should You Buy Agilysys, Inc. (NASDAQ:AGYS)?

Oct 03
When Should You Buy Agilysys, Inc. (NASDAQ:AGYS)?

Agilysys: A Compelling Growth Story With A Premium Valuation

Sep 26

If EPS Growth Is Important To You, Agilysys (NASDAQ:AGYS) Presents An Opportunity

Sep 18
If EPS Growth Is Important To You, Agilysys (NASDAQ:AGYS) Presents An Opportunity

Investor Optimism Abounds Agilysys, Inc. (NASDAQ:AGYS) But Growth Is Lacking

Aug 30
Investor Optimism Abounds Agilysys, Inc. (NASDAQ:AGYS) But Growth Is Lacking

Finding New Heights As Agilysys Drives Growth Amid Market Challenges

Jul 09

There's Been No Shortage Of Growth Recently For Agilysys' (NASDAQ:AGYS) Returns On Capital

Jul 01
There's Been No Shortage Of Growth Recently For Agilysys' (NASDAQ:AGYS) Returns On Capital

Shareholders Shouldn’t Be Too Comfortable With Agilysys' (NASDAQ:AGYS) Strong Earnings

May 21
Shareholders Shouldn’t Be Too Comfortable With Agilysys' (NASDAQ:AGYS) Strong Earnings

Why Investors Shouldn't Be Surprised By Agilysys, Inc.'s (NASDAQ:AGYS) P/S

May 04
Why Investors Shouldn't Be Surprised By Agilysys, Inc.'s (NASDAQ:AGYS) P/S

Agilysys: Time To Buy This GARP Small Cap

Mar 18

Should You Be Adding Agilysys (NASDAQ:AGYS) To Your Watchlist Today?

Mar 01
Should You Be Adding Agilysys (NASDAQ:AGYS) To Your Watchlist Today?

Agilysys (NASDAQ:AGYS) Might Have The Makings Of A Multi-Bagger

Jan 08
Agilysys (NASDAQ:AGYS) Might Have The Makings Of A Multi-Bagger

Investors Appear Satisfied With Agilysys, Inc.'s (NASDAQ:AGYS) Prospects

Dec 19
Investors Appear Satisfied With Agilysys, Inc.'s (NASDAQ:AGYS) Prospects

We Ran A Stock Scan For Earnings Growth And Agilysys (NASDAQ:AGYS) Passed With Ease

Oct 23
We Ran A Stock Scan For Earnings Growth And Agilysys (NASDAQ:AGYS) Passed With Ease

Returns At Agilysys (NASDAQ:AGYS) Are On The Way Up

Oct 07
Returns At Agilysys (NASDAQ:AGYS) Are On The Way Up

Should You Think About Buying Agilysys, Inc. (NASDAQ:AGYS) Now?

Aug 29
Should You Think About Buying Agilysys, Inc. (NASDAQ:AGYS) Now?

Is Agilysys, Inc. (NASDAQ:AGYS) Expensive For A Reason? A Look At Its Intrinsic Value

Aug 14
Is Agilysys, Inc. (NASDAQ:AGYS) Expensive For A Reason? A Look At Its Intrinsic Value

Do Agilysys' (NASDAQ:AGYS) Earnings Warrant Your Attention?

Jul 12
Do Agilysys' (NASDAQ:AGYS) Earnings Warrant Your Attention?

Agilysys, Inc.'s (NASDAQ:AGYS) Share Price Matching Investor Opinion

Jun 05
Agilysys, Inc.'s (NASDAQ:AGYS) Share Price Matching Investor Opinion

Agilysys (NASDAQ:AGYS) Is Doing The Right Things To Multiply Its Share Price

Mar 25
Agilysys (NASDAQ:AGYS) Is Doing The Right Things To Multiply Its Share Price

Returns At Agilysys (NASDAQ:AGYS) Are On The Way Up

Dec 03
Returns At Agilysys (NASDAQ:AGYS) Are On The Way Up

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AGYS's short term assets ($108.7M) exceed its short term liabilities ($95.9M).

Uzun Vadeli Yükümlülükler: AGYS's short term assets ($108.7M) exceed its long term liabilities ($85.9M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AGYS has more cash than its total debt.

Borcun Azaltılması: AGYS's debt to equity ratio has increased from 0% to 19.2% over the past 5 years.

Borç Kapsamı: AGYS's debt is well covered by operating cash flow (100.8%).

Faiz Kapsamı: AGYS earns more interest than it pays, so coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin